Resources
News

Michael K. Fee to Lead Verrill’s Nationally-Recognized Health Care and Life Sciences Practice Amidst Recent Changes

August 31, 2020 Press Releases

(August 31, 2020) – Verrill is pleased to announce Michael K. Fee as the new leader of Verrill’s nationally-recognized Health Care & Life Sciences Group. The Group has a long history of representing a broad range of providers, insurers, and other participants in the health care field. Fee joined the Group during the past year, bringing to it preeminent skills and experience as a white collar defense litigator and health care fraud and abuse advisor.

At the same time, Verrill is announcing the dissolution of a portion of its practice group focused on academic and clinical research matters. “We are naturally sorry to see colleagues in this niche field depart,” Fee commented. “But it will not impact Verrill’s longstanding and vibrant health care practice. We will continue to serve clients of all kinds who operate in the complex and highly regulated health care field.”

Verrill provides a full spectrum of legal services to organizations and individual professionals in health care. Through multidisciplinary collaboration, Verrill assists with critical matters like strategic affiliations and transactions, privacy and security, reimbursement, regulatory compliance, and the defense of health care industry players in government enforcement proceedings and litigation. The health care practice has experienced a great deal of growth over recent years, including the expansion of the health care and life sciences defense practice that Fee also leads.

“I am excited to lead such a strong array of attorneys with decades of experience and stature in the health care field. As our clients look to us now more than ever amidst the current pandemic, we will continue to serve the ever-evolving needs of our clients throughout New England and beyond, providing them with the highest level of client service and value they know and expect,” added Fee.

Verrill’s Health Care and Life Sciences Group and its Health Care Industry Group, composed of 20 Partners and Counsel, supported by energetic and talented associates, remain focused on using their unmatched knowledge and skill to deliver the highest level of client service to the firm’s health care industry clients from three of Verrill’s offices in New England.

Firm Highlights

News

Verrill Welcomes Health Care Attorney Alicia Siani

(February 2, 2021) – Verrill is pleased to welcome health care attorney Alicia Siani to the firm’s Boston, Massachusetts office. Siani represents clients in a wide range of regulatory issues, including HIPAA privacy matters...

Publication/Podcast

The Regulatory Sprint is Over - What’s at the Finish Line Under the New Stark and AKS Final Rules?

The U.S. Department of Health and Human Services (HHS) completed its “Regulatory Sprint” by finalizing changes to regulations pertaining to two federal fraud and abuse laws. On December 2, 2020, the Centers for Medicare...

Matter

Conflicts of Interest

Reviewed medical center's systems, policies and procedures for identifying, assessing, and managing investigator and institutional conflicts of interest.

Matter

Common Rule

Guided multiple clients through the implementation of the revised HHS regulations (the "Common Rule"), including reviewing and revising policies and procedures, and assisting with institutional approaches to implementation.

News

Verrill Ranked in American Bar Association’s Health Law Top 10 in the Northeast

(January 19, 2021) – Verrill was recently ranked third in the American Bar Association (ABA) Health Law Section's Eighth Annual Top 10 Recognition for the Northeast Region. This is the sixth consecutive year that...

Publication/Podcast

HHS Confirms Providers’ Right to 340B Discount Pricing for Contract Pharmacies

As a holiday gift to providers, the U.S. Department of Health and Human Services (HHS) General Counsel recently issued a strongly worded Advisory Opinion indicating that federal law requires drug manufacturers to deliver covered...

Matter

Multi-Site Global Research

Developed and negotiated site and coordinating center agreements in connection with a multi-site, international, National Institutes of Health (NIH)-funded study, and advised on regulatory issues related to the conduct of the study and subsequent...

Publication/Podcast

340B Providers Get Partial Relief from New Dispute Resolution Regulation

1. 340B ADR Process Established At long last, more than ten years after Congress directed it to do so, HHS has finalized an alternative dispute resolution (“ADR”) process for both providers and pharmaceutical manufacturers...

Publication/Podcast

Massachusetts Health Care Bill Makes Several Significant Changes

While you were celebrating the New Year, Governor Baker signed Chapter 260 of the Acts of 2020, an “Act promoting a resilient health care system that puts patients first,” the result of the Legislature’s...

Matter

European Union GDPR—Institution

Counseled a preeminent health system and academic medical center on its compliance with the European Union General Data Protection Regulation (GDPR) in relation to its clinical and research activities, including its international research studies...

Contact Verrill at (855) 307 0700